DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,000 | 0.0% | 266 | +88.7% | 0.00% | – |
| Q2 2021 | $5,000 | +25.0% | 141 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 141 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | -62.5% | 141 | -66.6% | 0.00% | – |
| Q3 2020 | $8,000 | +14.3% | 422 | +9.3% | 0.00% | – |
| Q2 2020 | $7,000 | 0.0% | 386 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -22.2% | 386 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | +50.0% | 386 | -11.5% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 436 | +9.3% | 0.00% | – |
| Q2 2019 | $6,000 | 0.0% | 399 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | 0.0% | 399 | -33.5% | 0.00% | – |
| Q4 2018 | $6,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |